FDA approves apalutamide for castration-resistant prostate cancer.
Jeff Cineas, PharmD Candidate
Advertisement
Articles by Jeff Cineas, PharmD Candidate
Advertisement
Latest Updated Articles
Apalutimide for Prostate Cancer: What to KnowPublished: April 4th 2018 | Updated:
Advertisement
Advertisement
Trending on Drug Topics
1
Pharmacists Must Effectively Balance Risks, Benefits of Social Media Use
2
FDA Approves Tradipitant for Prevention of Vomiting From Motion Sickness
3
New Survey Reveals Imminent Long-Term Care Crisis: 80% of America's Nursing Home Residents Face Loss of Access to Essential Prescription Drugs Pharmacy Services in 2026
4
Pharmacists Can Use Social Media for Professional, Educational Advancement
5